Abnormalities in Liver Iron Accumulation During N-2-Fluorenylacetamide Hepatocarcinogenesis that are Dependent or Independent of Continued Carcinogen Action
Free accessResearch articleFirst published online February, 1984
Abnormalities in Liver Iron Accumulation During N-2-Fluorenylacetamide Hepatocarcinogenesis that are Dependent or Independent of Continued Carcinogen Action
The characteristics of liver iron accumulation were studied during N-2-fluorenylacetamide (FAA)-induced hepatocarcinogenesis in rats. After injection of iron-dextran in control rats, hepatocytes accumulated stainable iron evenly throughout hepatic lobules. During the feeding of FAA, iron accumulation was reduced in the midzonal and centrilobular regions. After FAA removal, hepatocytes in these regions again accumulated high amounts of iron. Hepatocellular altered foci induced by FAA displayed rather uniform (> 94%) iron-exclusion during FAA feeding. After FAA removal, however, iron-exclusion was lost in a fraction of the foci, while others (40-64%) remained resistant to iron accumulation. A large majority of liver neoplasms (> 93%) displayed resistance to cellular iron accumulation both during FAA feeding and after removal of FAA. Thus, iron-exclusion by liver neoplasms is carcinogen-independent and irreversible, in contrast with that of normal hepatocytes which is completely carcinogen-dependent and reversible. Altered foci appear to represent two populations: one is characterized by reversible iron-exclusion whereas the other, like neoplasms, possesses permanent iron-exclusion.
References
1.
1. Butler WH, Newberne PM (1975): Morphology of Spontaneous and Induced Neoplasia. Mouse Hepatic Neoplasia. Elsevier Scientific Publishing Co., Amsterdam, pp. 1–195.
2.
2. Schauer, A, Kunze, E (1976): Tumors of the liver. In Pathology of Tumors in Laboratory Animals. Vol. 1 Tumors of the Rat. Int. Agency for Research on Cancer, Lyon, pp. 41–72.
3.
3. Stewart HL, Williams GM, Keysser H, Lombard LS, Montali RJ (1980): Histologic typing of liver tumors of the rat.J Natl Cancer Inst64: 177–207.
4.
4. Kitagawa T (1971): Histochemical analysis of hyperplastic lesions and hepatomas of the liver of rats fed 2-fluorenylacetamide.Gann62: 207–216.
5.
5. Rabes H, Scholze P, Jantsch B (1972): Growth kinetics of diethylnitrosamine-induced, enzyme-deficient “preneoplastic” liver cell populations in vivo and in vitro.Cancer Res32: 2577–2586.
6.
6. Williams GM (1976): Functional markers and growth behavior of preneoplastic hepatocytes.Cancer Res26: 2540–2543.
7.
7. Pugh TD, Goldfarb S (1978): Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital.Cancer Res38: 4450–4457.
8.
8. Hirota N, Williams GM (1979): The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis.Am J Pathol95: 317–324.
10. Farber E (1980): The sequential analysis of liver cancer induction.Biochim Biophys Acta605: 149–166.
11.
11. Williams GM (1980): The pathogenesis of rat liver cancer caused by chemical carcinogens.Biochim Biophys Acta605: 167–189.
12.
12. Pitot HC, Sirica AE (1980): The stages of initiation and promotion in hepatocarcinogenesis.Biochim Biophys Acta605: 191–215.
13.
13. Emmelot P, Scherer E (1980): The first relevant cell stage in rat liver carcinogenesis. A quantitative approach.Biochim Biophys Acta605: 247–304.
14.
14. Barbason H, Betz EH (1981): Proliferation of preneoplastic lesions after discontinuation of chronic DEN feeding in the development of hepatomas in rat.Br J Cancer44: 561–566.
15.
15. Williams GM, Yamamoto RS (1972): Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-in-duced siderosis.J Natl Cancer Inst49: 685–692.
16.
16. Williams GM, Klaiber M, Parker SE, Farber E (1976): Nature of early appearing carcinogen-induced liver lesions resistant to iron accumulation.J Natl Cancer Inst57: 157–165.
17.
17. Williams GM, Hirota N, Rice JM (1979): The resistance of spontaneous mouse hepatocellular tumors to iron accumulation during rapid iron loading by parenteral administration and their transplantability.Am J Pathol94: 65–74.
18.
18. Williams GM, Watanabe K (1978): Quantitative kinetics of development of N-2-fluorenylacetamide-induced. altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistance following removal of carcinogen.J Natl Cancer Inst61: 113–121.
19.
19. Williams GM (1982): Phenotypic properties of preneoplastic rat liver lesions and applications to detection of carcinogens and tumor promoters.Toxicol Pothol10: 3–10.
20.
20. Beaumont C, Le Rumeur E, Guillouzo C, Latinier MF, Bourel M, Guillouzo A (1981): Ferritin is increased in diethylnitrosamine-altered rat hepatocytes.Biochem Biophys Res Comm99: 879–885.
21.
21. Wilson RH, De Eds H, Cox AJ Jr (1941): The toxicity and carcinogenic activity of 2-acetylaminofluorene.Cancer Res1: 595–608.
22.
22. Warwick GP (1971): Metabolism of liver carcinogens and other factors influencing liver cancer induction. In: Liver Cancer, No. 1, IARC Scientific Publications, pp. 121–157.
23.
23. Flaks B (1979): Acute fine structural changes in rat hepatocytes induced by a single large dose of 2-acetylaminofluorene. Virchows Arch (Cell Pathol)29:309–320.
24.
24. Austin GE (1979): Quantitative and qualitative changes in RNA metabolism in rats fed N-2-acetylaminofluorene.Exp Molec Pathol3: 333–343.
25.
25. Flaks B, Nicoll JW (1974): Modification of toxic liver injury in the rat. I. Effect of inhibition of protein synthesis on the action of 2-acetylaminofluorene, carbon tetrachloride, 3′-methyl-4-dimethylamino-azobenzene and diethylnitrosamine.Chem-Biol Interact8: 135–150.
26.
26. Rouiller C (1964): Experimental toxic injury of the liver. In: The Liver, Vol II, C. Rouiller, ed., Academic Pres, NY. pp. 335.
27.
27. Pitot HC (1977): The stability of events in the natural history of neoplasia.Am J Pothol89: 703–716.
28.
28. Mori H, Tanaka T, Sugie S, Takahashi M, Williams GM (1982): DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci.J Natl Cancer Inst69: 1277–1282.
29.
29. Yamashita H (1979): Radio-iron uptake of rat hepatoma.Gann70: 593–600.
30.
30. Richter GW (1965): Comparison of ferritins from neoplastic and non-neoplastic human cells.Nature207: 616–618.
31.
31. Lindner M, Munro HN, Morris HP (1970): Rat ferritin isoproteins and their response to iron administration in a series of hepatic tumors and in normal and regenerating liver.Cancer Res30: 2231–2239.
32.
32. Lee JCK, Richter GW (1971): Distinctive properties of ferritin from the Reuber H-35 rat hepatoma.Cancer Res31: 566–572.
33.
33. Alpert E, Coston RL, Drysdale JW (1973): Carcinofetal human ferritins.Nature242: 194–196.
34.
34. Alpert E (1975): Characterization and subunit analysis of ferritin isolated from normal and malignant human liver.Cancer Res35: 1505–1509.
35.
35. Linder MC, Moor JR, Munro HN, Morris HP (1975): Structural differences in ferritins from normal and malignant rat tissue.Biochim Biophys Acta386: 409–421.
